You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

CLINICAL TRIALS PROFILE FOR LEXAPRO

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for LEXAPRO

Subscribe to access the full database, or Subscribe
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00071643 ↗	Preventing Post-Stroke Depression	Completed	National Institute of Mental Health (NIMH)	N/A	2002-09-01	This study will evaluate the effectiveness of both drug and non-drug treatments in preventing depression after a stroke.
NCT00071643 ↗	Preventing Post-Stroke Depression	Completed	Robert G. Robinson	N/A	2002-09-01	This study will evaluate the effectiveness of both drug and non-drug treatments in preventing depression after a stroke.
NCT00071643 ↗	Preventing Post-Stroke Depression	Completed	University of Iowa	N/A	2002-09-01	This study will evaluate the effectiveness of both drug and non-drug treatments in preventing depression after a stroke.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for LEXAPRO

Condition Name

Chart
Table

Condition Name for LEXAPRO
Intervention	Trials
Depression	42
Major Depressive Disorder	41
Anxiety	9
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for LEXAPRO
Intervention	Trials
Depression	102
Depressive Disorder	92
Depressive Disorder, Major	63
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for LEXAPRO

Trials by Country

Map
Table

Trials by Country for LEXAPRO
Location	Trials
United States	257
China	17
Canada	14
Korea, Republic of	9
Australia	9
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for LEXAPRO
Location	Trials
New York	27
California	19
Massachusetts	19
Pennsylvania	15
Texas	12
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for LEXAPRO

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for LEXAPRO
Clinical Trial Phase	Trials
Phase 4	78
Phase 3	11
Phase 2/Phase 3	9
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for LEXAPRO
Clinical Trial Phase	Trials
Completed	113
Recruiting	16
Unknown status	14
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for LEXAPRO

Sponsor Name

Chart
Table

Sponsor Name for LEXAPRO
Sponsor	Trials
National Institute of Mental Health (NIMH)	34
Forest Laboratories	25
Massachusetts General Hospital	11
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for LEXAPRO
Sponsor	Trials
Other	183
Industry	52
NIH	50
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.